C. Garrison Fathman

C. Garrison Fathman's AcademicInfluence.com Rankings

C. Garrison Fathman

Philosophy

#6015

World Rank

#8974

Historical Rank

#1486

USA Rank

Logic

#3209

World Rank

#4332

Historical Rank

#679

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is C. Garrison Fathman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, C. Garrison Fathman is a Professor of Medicine and Division Chief of Immunology and Rheumatology at Stanford University School of Medicine. He is also the Associate Director of the Institute for Immunity, Transplantation and Infection and Director of the Center for Clinical Immunology at Stanford University. He was Founder and first-President of the Federation of Clinical Immunology Societies. As Director of the CCIS, Dr. Fathman initiated a multidisciplinary approach to study and treat autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and insulin-dependent diabetes mellitus, and initiated several new approaches to education and community outreach.

(See a Problem?)

C. Garrison Fathman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment (2000) (3594)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation (2003) (1236)
Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation (2002) (1150)
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). (1996) (1056)
Polyarginine enters cells more efficiently than other polycationic homopolymers. (2000) (980)
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells (1989) (547)
The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens (2002) (517)
The Subpopulation of CD4+CD25+ Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR71 (2002) (441)
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. (2005) (441)
Exploiting a natural conformational switch to engineer an Interleukin-2 superkine (2012) (399)
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein (1996) (398)
Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. (1988) (373)
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. (2004) (356)
CD4+ but not CD8+ cells are essential for allorejection (1996) (316)
GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. (2003) (299)
Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis (1997) (279)
Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. (1992) (262)
Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen (1993) (258)
Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation (1980) (251)
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. (2002) (229)
Protein microarrays for multiplex analysis of signal transduction pathways (2004) (210)
Autoimmune diseases: genes, bugs and failed regulation (2001) (204)
Molecular mechanisms of CD4+ T-cell anergy (2007) (201)
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. (1997) (198)
T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages (1990) (193)
Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. (2001) (188)
The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides (1990) (180)
Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. (1987) (177)
Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 (2001) (177)
Two isoforms of otubain 1 regulate T cell anergy via GRAIL (2004) (176)
HLA and disease associations. (1978) (170)
CD4+CD25+ T Cells Facilitate the Induction of T Cell Anergy (2001) (152)
Abnormal migration of T lymphocyte clones. (1982) (150)
Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells (1981) (148)
Bioluminescence imaging of lymphocyte trafficking in vivo. (2001) (145)
Cd4+Cd25+ regulatory T cells and their therapeutic potential. (2006) (143)
Mechanisms of transplantation tolerance. (1994) (137)
Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes (2009) (130)
Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenvironment for T cell differentiation (1986) (129)
Modulation of CD4 by antigenic activation. (1987) (128)
Thymus cell maturation. II. Differentiation of three "mature" subclasses in vivo. (1975) (126)
Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant (1984) (123)
The Gene Related to Anergy in Lymphocytes, an E3 Ubiquitin Ligase, Is Necessary for Anergy Induction in CD4 T Cells1 (2004) (122)
Isolation, characterization, and utilization of T lymphocyte clones (1982) (122)
Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 (1986) (120)
INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI‐CD4 MONOCLONAL ANTIBODY THERAPY (1990) (116)
The structure of T-cell epitopes. (1987) (116)
Targeting Rare Populations of Murine Antigen-Specific T Lymphocytes by Retroviral Transduction for Potential Application in Gene Therapy for Autoimmune Disease1 (2000) (115)
Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. (1993) (114)
Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. (1999) (111)
Anti-CD4 mediates clonal anergy during transplantation tolerance induction (1991) (109)
Characterization of subpopulations of T lymphocytes. I. Separation and functional studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 (theta) antibody using a fluorescence-activated cell sorter (FACS). (1975) (108)
Intrathymic presentation of circulating non-major histocompatibility complex antigens (1984) (105)
An array of possibilities for the study of autoimmunity (2005) (105)
Breaking self-tolerance in nonobese diabetic mice (1996) (101)
Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. (2005) (100)
Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease1 (2007) (99)
Studies Utilizing Murine T Cell Clones Ir Genes, Ia Antigens and MLR Stimulating Determinants (1981) (95)
GRAIL : An E 3 Ubiquitin Ligase that Inhibits Cytokine Gene Transcription Is Expressed in Anergic CD 4 T Cells tumors (2003) (94)
Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene1 (2004) (93)
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. (1975) (90)
Correlation of T cell receptor V beta gene family with MHC restriction (1987) (89)
Clones of alloreactive T cells (1978) (89)
T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4+ T Cell Response in Vivo (2000) (88)
Islet-Infiltrating Lymphocytes from Prediabetic NOD Mice Rapidly Transfer Diabetes to NOD-scid/scid mice (1995) (88)
β-Cell Destruction May Be a Late Consequence of the Autoimmune Process in Nonobese Diabetic Mice (1996) (87)
Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging (2015) (84)
L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. (2005) (83)
Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse (1996) (82)
A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1 (1989) (79)
Therapeutic Effects of Systemic Administration of Chaperone αB-Crystallin Associated with Binding Proinflammatory Plasma Proteins* (2012) (78)
A Novel E3 Ubiquitin Ligase Substrate Screen Identifies Rho Guanine Dissociation Inhibitor as a Substrate of Gene Related to Anergy in Lymphocytes1 (2006) (78)
The Single Subunit Transmembrane E3 Ligase Gene Related to Anergy in Lymphocytes (GRAIL) Captures and Then Ubiquitinates Transmembrane Proteins across the Cell Membrane* (2008) (76)
Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. (1998) (75)
GRAIL Is Up-regulated in CD4+ CD25+ T Regulatory Cells and Is Sufficient for Conversion of T Cells to a Regulatory Phenotype* (2007) (75)
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines (2012) (75)
Autoantibody‐Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity (2016) (75)
Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis. (1986) (73)
Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. (2001) (70)
Anti‐CD4 Monoclonal Antibodies in Therapy: Creation of Nonclassical Tolerance in the Adult (1992) (67)
Monoclonal T cells identified in early NOD islet infiltrates. (1996) (66)
Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. (2008) (66)
Cutting Edge: The Transmembrane E3 Ligase GRAIL Ubiquitinates the Costimulatory Molecule CD40 Ligand during the Induction of T Cell Anergy1 (2008) (64)
Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. (2009) (64)
H‐2 gene complementation in cytotoxic T cell responses of female against male cells (1977) (62)
Distinct B Cell Subpopulations Differ in Their Genetic Requirements for Activation by T Helper Cells (1982) (61)
Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant. (1976) (60)
CD45RBhigh CD4+ T cells from IFN-γ knockout mice do not induce wasting disease (1997) (60)
Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones (1982) (59)
Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. (1996) (58)
New tools for classification and monitoring of autoimmune diseases (2012) (58)
Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. (1999) (57)
A new look at the shared epitope hypothesis. (1988) (56)
CD4-positive suppressor cells block allotransplant rejection. (1995) (55)
Treatment of Autoimmune Disease by Adoptive Cellular Gene Therapy (2003) (55)
T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin (1981) (54)
T-lymphocyte clones. (1983) (54)
Isolation of Nonobese Diabetic Mouse T-Cells That Recognize Novel Autoantigens Involved in the Early Events of Diabetes (1994) (54)
Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. (1981) (54)
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy (2015) (53)
Role of the major histocompatibility complex in T cell activation of B cell subpopulations. A single monoclonal T helper cell population activates different B cell subpopulations by distinct pathways (1982) (53)
Clonal Growth of T Cells in vitro: Preliminary Attempts to a Quantitative Approach (1977) (52)
It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes (2013) (52)
T‐Lymphocyte Subsets During Pregnancy and the Menstrual Cycle (1983) (52)
EVIDENCE FOR A ROLE OF Ir-ASSOCIATED ALLOANTIGENS IN MIXED LYMPHOCYTE CULTURE STIMULATION (1974) (51)
Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. (2008) (51)
In vitro secondary mixed leukocyte reaction (MLR) (1977) (50)
In vitro secondary MLR. I. Kinetics of proliferation and specificity of in vitro primed responder cells. (1977) (49)
The T cell receptor repertoire influences V beta element usage in response to myoglobin (1991) (48)
Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig. (1995) (48)
T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-A (k) antibodies (1982) (47)
MHC structure and autoimmune T cell repertoire development. (1999) (47)
Pillars article: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000. 100: 655-669. (2015) (45)
The Transmembrane E3 Ligase GRAIL Ubiquitinates and Degrades CD83 on CD4 T Cells1 (2009) (43)
Immune regulation in type 1 diabetes. (1996) (43)
The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. (1998) (41)
Naive CD4 T Cell Proliferation Is Controlled by Mammalian Target of Rapamycin Regulation of GRAIL Expression1 (2009) (41)
Regulation of autoimmune response. (1994) (41)
Vitamin D Deficiency in a Multiethnic Healthy Control Cohort and Altered Immune Response in Vitamin D Deficient European-American Healthy Controls (2014) (39)
The effects of autacoids on cloned murine lymphoid cells: modulation of IL 2 secretion and the activity of natural suppressor cells. (1985) (39)
New tools for classification and monitoring of autoimmune diseases (2012) (39)
Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response (1986) (38)
Immunochemical properties of human low density lipoproteins as explored by monoclonal antibodies. Binding characteristics distinct from those of conventional serum antibodies. (1982) (38)
The I-Ab mutant B6.C-H-2bm12 allows definition of multiple T cell epitopes on I-A molecules (1983) (38)
A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. (2010) (38)
Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. (1994) (38)
CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. (1997) (37)
Genetic control of the immune response to nuclease. V. Genetic linkage and strain distribution of anti-nuclease idiotypes (1977) (37)
Crossreactive mixed lymphocyte reaction determinants recognized by cloned alloreactive T cells. (1979) (34)
Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. (1996) (34)
Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity (1984) (34)
Genetic dissection of T cell receptor V beta gene requirements for spontaneous murine diabetes (1991) (34)
Presentation of antigen by mixed isotype class II molecules in normal H- 2d mice (1992) (33)
Human T-cell clones used to define functional epitopes on HLA class II molecules. (1986) (33)
Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis (2003) (33)
Costimulatory signals controlling regulatory T cells (2003) (33)
Antigen-reactive T cell clones. II. Unique homozygous and (high responder x low responder)F1 hybrid antigen-presenting determinants detected using poly(Tyr, Glu)-poly D, L-Ala--poly Lys-reactive T cell clones (1981) (32)
Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. (1999) (32)
Gene therapy in autoimmune disease. (2000) (31)
Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. (2013) (30)
Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. (1997) (30)
Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. (2002) (30)
Diminished Adenosine A1 Receptor Expression in Pancreatic α-Cells May Contribute to the Pathology of Type 1 Diabetes (2013) (29)
SEB induced anergy: modulation of immune response to T cell determinants of myoglobin and myelin basic protein. (1993) (29)
Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression. (1991) (29)
Administration in vivo of recombinant interleukin 2 protects mice against septic death. (1987) (28)
Expression-Based Genome-Wide Association Study Links Vitamin D–Binding Protein With Autoantigenicity in Type 1 Diabetes (2016) (28)
EVIDENCE THAT CLONAL ANERGY IS INDUCED IN THYMIC MIGRANT CELLS AFTER ANTI‐CD4-MEDIATED TRANSPLANTATION TOLERANCE (1993) (28)
Regulation of programmed cell death following T cell activation in vivo. (1998) (28)
Ligand-Independent Down-Regulation of IFN-γ Receptor 1 Following TCR Engagement1 (2000) (27)
Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. (1996) (26)
Functional helper activity of monoclonal T cell populations: antigen-specific and H-2 restricted cloned T cells provide help for in vitro antibody responses to trinitrophenyl-poly(LTyr,Glu)-poly(DLAla)--poly(LLys). (1981) (26)
Type II collagen-reactive T cell clones from mice with collagen-induced arthritis. (1985) (26)
Immunotherapeutic strategies directed at the trimolecular complex. (1994) (26)
The application of gene therapy in autoimmune diseases (2000) (26)
New technologies for autoimmune disease monitoring (2010) (25)
Dengue-2 Structural Proteins Associate with Human Proteins to Produce a Coagulation and Innate Immune Response Biased Interactome (2011) (24)
Adoptive cellular gene therapy of autoimmune disease. (2002) (24)
Human T cell clones express functional homing receptors required for normal lymphocyte trafficking (1985) (23)
Antigen-reactive T clones. III. Low responder antigen-presenting cells function effectively to present antigen to selected T cell clones derived from (High Responder x Low Responder)F1 mice (1981) (23)
Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. (2007) (23)
Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates. (1998) (23)
Genetic control of the immune response to nuclease. II. Detection of idiotypic determinants by the inhibition of antibody-mediated nuclease inactivation. (1976) (23)
Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. (1990) (22)
Clones of alloreactive T cells. I. A. unique homozygous MLR-stimulating determinant present on B6 stimulators. (1980) (22)
The potential for gene therapy in the treatment of autoimmune disease. (2002) (22)
CARDIAC ALLOGRAFT PROLONGATION IN MICE TREATED WITH COMBINED POSTTRANSPLANTATION TOTAL‐LYMPHOID IRRADIATION AND ANTI‐L3T4 ANTIBODY THERAPY (1989) (21)
Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. (1985) (21)
Arsonate-specific murine T cell clones. I. Genetic control and antigen specificity (1983) (21)
Inflammation and Hyperglycemia Mediate Deaf1 Splicing in the Pancreatic Lymph Nodes via Distinct Pathways During Type 1 Diabetes (2014) (21)
Rapid and Efficient Vascular Transport of Arginine Polymers Inhibits Myointimal Hyperplasia (2000) (21)
Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance. (2007) (20)
Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2. (1989) (19)
Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease (2015) (19)
Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. (1980) (18)
USE OF ANTI‐L3T4 AND ANTI‐Ia TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS (1988) (18)
Identification of a common immune regulatory pathway induced by small heat shock proteins, amyloid fibrils, and nicotine (2018) (18)
Cyclosporine therapy for autoimmune disease. (1992) (18)
Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responses. (1989) (18)
Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4 (2001) (18)
Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis (2014) (18)
Targeted gene therapy: frontiers in the development of 'smart drugs'. (2004) (18)
THE USE OF GRANZYME A AS A MARKER OF HEART TRANSPLANT REJECTION IN CYCLOSPORINE OR ANTI‐CD4 MONOCLONAL ANTIBODY‐TREATED RATS (1993) (18)
The immune response to staphylococcal nuclease: a probe of cellular and humoral antigen-specific receptors. (1977) (17)
In vitro secondary MLR. III: Hybrid histocompatibility determinants. (1978) (17)
Gene therapy for autoimmune disease. (2001) (17)
Molecular analysis of the role of the HLA class II genes DRB1, DQA1, DQB1, and DPB1 in susceptibility to Lyme arthritis. (1991) (17)
Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo. (2000) (16)
Poly-L-arginine topical lotion tested in a mouse model for frostbite injury. (2014) (16)
Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. (1998) (16)
Anti-CD8 Abrogates Effect of Anti-CD4–Mediated Islet Allograft Survival in Rat Model (1991) (16)
Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis. (2012) (15)
Differentiation of thymus cells (1975) (15)
High cell surface expression of CD4 allows distinction of CD4+CD25+ antigen-specific effector T cells from CD4+CD25+ regulatory T cells in murine experimental autoimmune encephalomyelitis (2007) (14)
Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. (2000) (14)
Clonotypic Antibodies which Stimulate T Cell Clone Proliferation (1984) (14)
Heterogeneity of signal requirements in T cell activation within a panel of human proliferative T cell clones. (1987) (13)
Immunosuppression by anti-CD4 treatment in vivo. Cellular and humoral responses to alloantigens. (1989) (13)
Production of alloreactive T-cell lymphomas (1980) (13)
Clones of alloreactive T cells (1980) (12)
Selection for amino acid sequence and J beta element usage in the beta chain of DBA/2V beta b- and DBA/2V beta a-derived myoglobin-specific T cell clones. (1993) (12)
Limited T cell receptor beta-chain usage in the sperm whale myoglobin 110-121/E alpha dA beta d response by H-2d congenic mouse strains. (1992) (12)
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease (2014) (12)
Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes (2016) (12)
A complicated relationship: fulfilling the interactive needs of the T lymphocyte and the dendritic cell (2002) (11)
Two independent pathways of helper activity provided by a single T cell clone. (1986) (11)
Short polymers of arginine rapidly translocate into vascular cells: effects on nitric oxide synthesis. (2002) (11)
INHIBITION OF RAT MIXED LYMPHOCYTE PANCREATIC ISLET CULTURES WITH ANTI‐Ia IMMUNOTOXIN (1986) (11)
T cell anergy: where it's LAT. (2006) (10)
Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? (2006) (10)
Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis. (1998) (10)
Hybrid I region antigens. (1980) (10)
T-cell anergy (2003) (10)
Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes (2020) (9)
I-Region genetic restrictions imposed upon the recognition of KLH by murine T-cell clones (2004) (9)
Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes (2017) (9)
Murine T cell clones. (1987) (8)
Immunogenetics of rheumatoid arthritis. (1989) (7)
Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. (2004) (7)
IL 2 restores memory B cell activation by antigen-specific T cell clone variants. (1986) (7)
30. Defining the spectrum of clinical immunology. (2003) (7)
THE EFFECTIVENESS OF ANTI‐Ia-IMMUNOTOXINS IN THE SUPPRESSION OF MLR (1985) (7)
Selective T-cell depletion with Ox-38 anti-CD4 monoclonal antibody prevents cardiac allograft rejection in rats. (1990) (7)
Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis. (2006) (7)
Gene Conversion A Mechanism to Explain HLA‐D Region and Disease Association a (1986) (6)
Tissue-specific effects of anti-CD4 therapy in induction of allograft unresponsiveness in high and low responder rats. (1995) (6)
Naive CD 4 T Cell Proliferation Is Controlled by Mammalian Target of Rapamycin Regulation of GRAIL Expression 1 (2009) (6)
Non-H-2 linked control of low versus high responses of antigen-induced lymph node cell proliferation: possible role for antigen-presenting cells. (1979) (6)
Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway. (1982) (6)
The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection. (1997) (6)
Cloning of human alloreactive T cells. (1987) (5)
Biologic and Gene Therapy of Autoimmune Disease (2000) (5)
EVIDENCE THAT ANTI‐CD8 ABROGATES ANTI‐CD4‐MEDIATED CLONAL ANERGY BUT ALLOWS ALLOGRAFT SURVIVAL IN MICE (1993) (5)
A gene therapy approach to treatment of autoimmune disease (1998) (5)
Detection of antibodies to ia antigens in h-2 alloantisera. (1975) (5)
T cells which proliferate in response to concanavalin A include cells which proliferate in mixed leukocyte reactions (1977) (5)
“INTERACTION” MLR STIMULATING DETERMINANTS EXPRESSED ON F1 CELLS (1978) (4)
26 – Alloreactive T Cell Clones Which Recognize Hybrid Determinants (1982) (4)
Th1 unresponsiveness can be infectious for unrelated antigens (1998) (4)
Memory CD4 T Cells Induce Graft Versus Host Disease. (2005) (4)
Immunomodulatory vaccination in autoimmune disease. (2002) (4)
CYLD: deubiquitination-induced TCR signaling (2006) (4)
This information is current as Anergy in Lymphocytes Inhibitor as a Substrate of Gene Related to Screen Identifies Rho Guanine Dissociation A Novel E 3 Ubiquitin Ligase Substrate (2006) (4)
Anti-CD4 antibodies in diabetes. (1993) (4)
THE ROLE OF Ia ANTIGENS IN MLC STIMULATION (1976) (3)
32 – Mechanism of B Cell Activation by Monoclonal T Helper Cell Populations (1982) (3)
33 – T Cell Lines and T Cell Clones Bearing Cross-Reactive Idiotype (1982) (3)
Preparation of Mouse Antisera against Histocompatibility Antigens (1979) (3)
Hybrid I region antigens and I region restriction of recognition in MLR (1979) (3)
Myoglobin-reactive T cell clones. (1982) (3)
Human T cell clones as diagnostic tools and potential therapeutic reagents. (1986) (3)
CD4‐positive/heat‐stable antigen‐positive thymocytes cause graft‐versus‐host disease across non‐major histocompatibility complex incompatibilities (1994) (3)
Differentiation of thymus cells-1,2. (1975) (3)
Identification of Novel Disease-Relevant Genes and Pathways in the Pathogenesis of Type 1 Diabetes: A Potential Defect in Pancreatic Iron Homeostasis. (2022) (2)
Application of gene therapy in autoimmune disease. (2000) (2)
Targeted gene therapy of autoimmune diseases: advances and prospects (2005) (2)
Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. (2005) (2)
DRB1*LY10 — a newDRB1 allele and its haplotypic association (2005) (2)
Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease. (2006) (2)
Aberrant Regulation of Wnt/Beta-Catenin Pathway Mediators in Chronic Myelogenous Leukemia Stem Cells. (2006) (2)
Regulation of the immune response (1982) (2)
E05 Tissue- and age-specific changes in gene expression in autoimmune diabetes (2010) (2)
Understanding the interaction of genetics and cellular responses in nonobese diabetic mice. (2001) (2)
The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. (2020) (2)
Analysis of the ternary complex of antigen, MHC and T-cell receptor: the influence of the T-cell receptor V beta repertoire on the V beta gene element usage. (1991) (2)
16 – The Cloning of Alloreactive T Cells (1981) (1)
An analysis of monoclonal T cell and antibody recognition sites on Ia molecules. (1985) (1)
Stimulating the lymphocytes (1993) (1)
Monoclonal antibodies: tools of the future. (1980) (1)
protects from lethal acute GVHD Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells (2013) (1)
Inhibition of immune induction: the target of current transplantation tolerance strategies. (1992) (1)
Analysis of the ternary complex of antigen, MHC and T-cell receptor: the influence of the T-cell receptor Vβ repertoire on the Vβ gene element usage (1991) (1)
Functional Evidence for Two Antigen Presentation Sites for a Single I-A Molecule (1983) (1)
Peptides as therapy of autoimmune disease. (1993) (1)
Induction of T Cell Anergy Costimulatory Molecule CD 40 Ligand during Ligase GRAIL Ubiquitinates the Cutting Edge : The Transmembrane E 3 (2008) (1)
What a rheumatologist needs to know about T cell receptor structure and function. (1992) (1)
30 – An Analysis of T Cell Antigen Recognition Utilizing T Cell Clones (1982) (1)
Brief Definitive Reports) EVIDENCE FOR A ROLE OF /r-ASSOCIATED ALLOANTIGENS IN MIXED LYMPHOCYTE CULTURE STIMULATION (1974) (1)
Genetic Control of the Immune Response to Nuclease (1976) (1)
F.86. Deaf1 Isoforms Control Changes in Peripheral Tissue Antigen Gene Expression in the Non-obese Diabetic Mouse Pancreatic Lymph Node during Type I Diabetes Pathogenesis (2009) (1)
CD4+CD25+ Regulatory T Cells as Adoptive Cell Therapy for Autoimmune Disease and for the Treatment of Graft-Versus-Host Disease (2008) (1)
OF EXOGENOUS PROTEIN ANTIGENS BY DENDRITIC CELLS TO T CELL CLONES Intact Protein Is Presented Best by Immature , Epidermal Langerhans Cells (2003) (1)
GRAIL, an E3 ubiquitin ligase, is necessary for anergy induction in CD4+ T cells (2004) (1)
Only the CD62L (cid:1) subpopulation of CD4 (cid:1) CD25 (cid:1) regulatory T cells protects from lethal acute GVHD (2005) (1)
One I Region Restriction Determinant Can Associate with Multiple Antigenic Epitopes (1986) (1)
Adoptive Immunotherapy of Experimental Autoimmune Hearing Loss via T Cell Delivery of the IL-12 p40 Subunit (2009) (1)
OR.78. Immature Dendritic Cells As Vehicles for Application in Adoptive Cellular Gene Therapy (2006) (1)
Proliferation of T cell clones requires signals in addition to the pertubation of the T cell receptor - CD/sup 3/ complex (1986) (0)
Future of the subspecialty of allergy and immunology 30. Defining the spectrum of clinical immunology (2003) (0)
CD4 + CD25 + REGULATORY TC ELLS AND THEIR THERAPEUTIC POTENTIAL (2006) (0)
More Than a Diagnostic Code: Dr. C. Garrison Fathman, Washington University School of Medicine in St. Louis Commencement (2015) (0)
Ectopic expression and presentation of diabetogenic antigens in the lymph nodes of NOD mice. (171.10) (2012) (0)
8Trafficking of ex vivo expanded donor derived dendritic cells after allogeneic BMT (2003) (0)
Functional Characterization Of Hybrid Ia antigens (2019) (0)
Production of antibodies in vitro in cultures of murine lymphocytes. (1987) (0)
Interleukin-2 mutant D10 (2012) (0)
Cloned t cells provide antigen-specific and h-2 restricted help in an igm antibody response. Abstr. (1981) (0)
The Use of Human T Cell Clones to Dissect HLA and Disease Associations (1986) (0)
Effect of acute and chronic administrations of d penicillamine upon lymph node cell proliferative responses (1981) (0)
Correction: Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein (1998) (0)
Alteration of human in vitro T cell proliferative response in atopy: Decreased autologous MLR in atopics and depression of proliferative response to specific allergen after immunotherapy (1981) (0)
The conundrum of immune response: Two Ia loci specifically control multiple immune responses (1984) (0)
Midwinter conference of immunologists. (1982) (0)
OR.37. shRNA Mediated Downregulation of Genes Identified as ‘Core Transcriptome’ in Murine T Regulatory Cells (2008) (0)
Functional sites on Ia molecules. (1985) (0)
Regulation of Hematopoietic Differentiation and Its Disruption Group Report (1985) (0)
Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes (2017) (0)
T Cells Involved in Inductive Events in the Pathogenesis of Autoimmune Diabetes Mellitus (1993) (0)
Monoclonal antibodies: the next attempt at tumor immunotherapy. (1981) (0)
Functional similarities of AeE alpha Ia molecules as determined by analysis with T-cell clones. (1982) (0)
The gene related to anergy in lymphocytes regulates stat-mediated differentiation of CD4 T cells via ubiquitination and degradation of the kinase chaperone CDC37 (P1128) (2013) (0)
Meeting of The Federation of Clinical Immunology Societies (FOCIS) Paris—15–19 May 2003 Guest editors: C.G. Fathman and D. Hafler: Introduction (2003) (0)
Immunotoxins: A Perspective (1987) (0)
Detection of ia antigens on thymocytes. Abstr. (1975) (0)
Survival and homing of ex vivo expanded donor derived dendritic cells after allogeneic BMT (2004) (0)
F.82. GRAIL, An E3 Ligase, Is Differentially Regulated By TCR-Dependent and CD28-Dependent IL-2 Signals (2006) (0)
The effectiveness of anti-Ia-immunotoxins in the suppression of MLR. (1985) (0)
Mechanisms of autoimmunity / Part B (1997) (0)
OR.85. Regulation of GRAIL Expression by mTOR Controls Naive CD4 T Cell Proliferation (2009) (0)
ExpressionRegulation of GRAIL Controlled by Mammalian Target of Naive CD4 T Cell Proliferation Is (2010) (0)
Compositions et methodes de traitement de maladies (2005) (0)
SLE patients and autoantibody-positive healthy individuals display unique cytokine profiles: shared features of inflammation as well as select features of immunosuppression in autoantibody-positive healthy individuals (2012) (0)
Annual Review of Immunology (1984) (0)
How GRAIL controls Treg function to maintain self-tolerance (2022) (0)
Autoimmune Diseases: Gene Therapy (2007) (0)
Delivery of the IL-12 p40 Subunit Autoimmune Encephalomyelitis Via T Cell Adoptive Immunotherapy of Experimental (2001) (0)
ErratumT Cell Anergy: Where It's LAT (2006) (0)
29 – An Overview (1982) (0)
Reconstitution ofIrgenes, Iaantigens, andmixedlymphocyte reaction determinants bygenecomplementation (1981) (0)
Scratching the (T cell) surface (2003) (0)
GRAIL targets CDC37 to maintain CD4 T cell unresponsiveness (50.9) (2011) (0)
T.14. A Short Pulse of IL-4 Delivered Locally by mRNA Electroporated DCs is Sufficient to Prevent or Treat Autoimmune Diabetes in NOD Mice (2009) (0)
Functional similarities of AeEα Ia molecules as determined by analysis with T-cell clones (2004) (0)
Targeting mTOR and MAPK Pathways to Inhibit Naïve and Experienced Effector CD4 T Cells in Autoimmunity (2010) (0)
Bioluminescent tracking of candidate leukemic stem cell engraftment in immunocompromised mice (2005) (0)
Experimental “autoimmune” versus “allergic” encephalomyelitis (1998) (0)
Genethe Proximal Promoter Region of the IL-2 to Undergo Chromatin Remodeling Across Regulatory T Cells Fail + CD25+ Murine CD4 (2004) (0)
The induction of T lymphocyte anergy: Ras dependence and IL-2 transcription revisited (1998) (0)
Autoantibody-positive healthy individuals display unique immune profiles that regulate autoimmunity (HUM3P.244) (2015) (0)
OR.101. Time-dependent and Tissue-specific Changes in Gene Expression During Disease Induction and Progression in NOD Mice (2008) (0)
Gene Expression Analysis by Microarray Following Anti-CD3 Antibody Therapy of NOD Mice (2007) (0)
CostimulationAutoimmune Disease: Modulation of T Cell Encoding a Self-Peptide Prevents Suppressive Immunization with DNA (1999) (0)
The CD8 (cid:2) (cid:3) Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens (2002) (0)
Microsoft Word-JBC resubmittal Dec 28.docx (2011) (0)
Ternary complex therapy for autoimmune disease. (1995) (0)
Error in description of virus antigen system. (1989) (0)
Inflammation-induced splicing of Deaf1 in the pancreatic lymph nodes during the progression of Type 1 diabetes (P5061) (2013) (0)
TISSUE-SPECIFIC, DISEASE-RELATED GENE EXPRESSION IN T1D (2013) (0)
Targeted Cellular Gene Therapy Using IL-4 Secreting DCs Corrects Immune Dysregulations and Prevents Diabetes in NOD Mice (2007) (0)
Engineering cell-type selective immune responses using mechanism-based designer IL-4 cytokines. (57.8) (2011) (0)
Sa.86. The Earliest Islet-infiltrating T Cells in NOD Mice (2008) (0)
Erratum (2005) (0)
Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases. (1992) (0)
Annual review of immunology, vol. 20, 2002 (2003) (0)
Identification of Candidate IDDM Disease Susceptibility Genes in the Idd Regions of NOD Mice by Temporal Microarray Gene Expression Data Analysis (2007) (0)
Inflammation-induced Changes in Deaf1 Splicing Alter Peripheral Tissue Antigen Gene Expression in the Pancreatic Lymph Node during the Pathogenesis of Type I Diabetes (2010) (0)
The conundrum of immune response: two Ia loci specifically control multiple immune responses. (1984) (0)
Interleukin-4 mutant RGA bound to cytokine receptor common gamma (2012) (0)
Correction: Omitted Author (1993) (0)
Gene therapy for multiple sclerosis (2000) (0)
Retroviral Transduction of Antigen-Specific CD4+ T Cells for Local Delivery of Regulatory Molecules (2002) (0)
Fostering interdisciplinary immunology (2005) (0)
Multiple Restriction Sites Per la Molecule Recognized by T Cell Clones (1983) (0)
In Vitro Secondary MLR (1977) (0)
Engagement Receptor 1 Following TCR γ IFN-Ligand-Independent Down-Regulation of Fathman (2000) (0)
Erratum: Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation (Transplantation (July 15, 2005) 80, (134-139)) (2005) (0)
FUNCTIONAL STUDIES OF IMMUNE RESPONSE UTILIZING MURINE T CELL CLONES (1982) (0)
F.80. The TransmembraneE3 Ligase, GRAIL Ubiquitinates and Degrades CD83 on CD4+ T cells (2009) (0)
Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis (2014) (0)
Book ReviewBasic Immunogenetics Introduction to Molecular Immunology (1985) (0)
F.124. CTLA-4 Ig Serves as a Surrogate for Tregs by Engaging Activation Induced CD80/86 on Murine T Effector Cells (2009) (0)
The Interrelationship of Ia, Ir and MLR Examined with T Cell Clones (1981) (0)

This paper list is powered by the following services:

Other Resources About C. Garrison Fathman

en.wikipedia.org

What Schools Are Affiliated With C. Garrison Fathman?

C. Garrison Fathman is affiliated with the following schools: